- Home
- KGEI vs TRDA Comparison
KGEI vs TRDA Comparison
Compare KGEI & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KGEI
- TRDA
- Stock Information
- Founded
- KGEI 2008
- TRDA 2016
- Country
- KGEI United States
- TRDA United States
- Employees
- KGEI N/A
- TRDA N/A
- Industry
- KGEI
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- KGEI
- TRDA Health Care
- Exchange
- KGEI Nasdaq
- TRDA Nasdaq
- Market Cap
- KGEI 254.9M
- TRDA 264.5M
- IPO Year
- KGEI N/A
- TRDA 2021
- Fundamental
- Price
- KGEI $6.14
- TRDA $6.32
- Analyst Decision
- KGEI Strong Buy
- TRDA Strong Buy
- Analyst Count
- KGEI 1
- TRDA 3
- Target Price
- KGEI $11.00
- TRDA $25.67
- AVG Volume (30 Days)
- KGEI 508.9K
- TRDA 150.3K
- Earning Date
- KGEI 08-11-2025
- TRDA 08-12-2025
- Dividend Yield
- KGEI N/A
- TRDA N/A
- EPS Growth
- KGEI 42.32
- TRDA N/A
- EPS
- KGEI 0.57
- TRDA 0.61
- Revenue
- KGEI $60,739,000.00
- TRDA $172,220,000.00
- Revenue This Year
- KGEI $32.19
- TRDA N/A
- Revenue Next Year
- KGEI $33.24
- TRDA N/A
- P/E Ratio
- KGEI $10.71
- TRDA $10.32
- Revenue Growth
- KGEI 20.06
- TRDA 5.74
- 52 Week Low
- KGEI $2.85
- TRDA $6.23
- 52 Week High
- KGEI $9.89
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- KGEI 43.83
- TRDA 37.00
- Support Level
- KGEI $5.55
- TRDA $6.26
- Resistance Level
- KGEI $6.08
- TRDA $6.63
- Average True Range (ATR)
- KGEI 0.51
- TRDA 0.39
- MACD
- KGEI -0.08
- TRDA -0.04
- Stochastic Oscillator
- KGEI 18.66
- TRDA 7.98
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.